The vaccine is the product of an $18.9 million contract Greffex received in September 2019 from the National Institute of Health’s National Institute for Allergy and Infectious Diseases, aimed at fighting infectious threats, the Business Journal reported.
...
If it works, that would be a bargain for the taxpayer.
$18.9 million would not include the cost to receive FDA approva.l
Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, according to a new study by a team including researchers from Johns Hopkins Bloomberg School of Public Health...The $19 million median figure represents less than one percent of the average total cost of developing a new drug, which in recent years has been estimated at between $2 to $3 billion..for some indications, such as rare incurable diseases, the FDA will accept much smaller, shorter trialshttps://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html
Is this is not usually mentioned when liberals cite the cost of domestically produced drugs?